Beige adipocyte differentiation within white adipose tissue, referred to as browning, is seen as a possible mechanism for increasing energy expenditure. The molecular regulation underlying the thermogenic browning process has not been entirely elucidated. Here, we identify the zinc finger transcription factor EGR1 as a negative regulator of the beige fat program. Loss of Egr1 in mice promotes browning in the absence of external stimulation and leads to an increase of Ucp1 expression, which encodes the key thermogenic mitochondrial uncoupling protein-1. Moreover, EGR1 is recruited to the proximal region of the Ucp1 promoter in subcutaneous inguinal white adipose tissue. Transcriptomic analysis of subcutaneous inguinal white adipose tissue in the absence of Egr1 identifies the molecular signature of white adipocyte browning downstream of Egr1 deletion and highlights a concomitant increase of beige differentiation marker and a decrease in extracellular matrix gene expression. Conversely, Egr1 overexpression in mesenchymal stem cells decreases beige adipocyte differentiation, while increasing extracellular matrix production. These results reveal a role for Egr1 in blocking energy expenditure via direct Ucp1 transcription repression and highlight Egr1 as a therapeutic target for counteracting obesity.
White fat browning is a mechanism that produces heat and limits weight gain. The understanding of the molecular regulation underlying white fat browning has sparked interest to counteract obesity.
The adipose tissue of humans and other mammals contains white adipose tissue (WAT) and brown adipose tissue (BAT). WAT and BAT are developmentally and functionally distinct and contain white and brown adipocytes, respectively1,2,3. More recently, a third type of adipocytes has been described within WAT, beige adipocytes. Morphological and molecular analyses showed that brown and beige adipocytes are remarkably similar and express the same thermogenic markers4. However beige adipocytes, in contrast to brown adipocytes, express thermogenic markers only after external stimulations, such as cold exposure, starvation, exercise or hormone treatment5. In the adult, beige adipocytes are produced by the trans-differentiation of mature white adipocytes4 or by de novo differentiation of progenitors6 in response to external stimulations. This process is referred to as “browning” or “beigeing”2,7.
Because the increase of WAT is observed in many metabolic diseases, WAT browning represents a promising therapeutic approach. Consequently, it is crucial to decipher the molecular aspects underlying the beige differentiation program. Adipogenesis is triggered by a core adipogenic network, starting with the expression of Cebpb (CCAAT/enhancer binding protein ß), which activates the expression of Pparg (Peroxisome proliferator-activated receptor γ) and Cebpa (CCAAT/enhancer binding protein α), which in turn activates Ppara (Peroxisome proliferator-activated receptor α) expression8. Consistent with its thermogenic function, brown/beige differentiated adipocytes express high levels of UCP1, a mitochondrial protein that uncouples oxidative phosphorylation from ATP synthesis9,10. The Krebs cycle enzymes, such as OGDH (oxoglutarate dehydrogenase), SUCLA2 (succinate-Coenzyme A ligase) and COX8B (Cytochrome C Oxidase Subunit VIIIb)11,12 are also involved in heat production in beige/brown adipose tissue. Consistent with their anti-fat function, brown/beige differentiated adipocytes express factors involved in lipolysis such as PLIN5 (Perilipin 513) and CIDEA (Cell Death-Inducing DFFA-Like Effector A12). Beige adipocyte differentiation relies on the expression of a set of transcriptional activators2,3. PRDM16 (PR domain containing 16) is considered as a master regulator of the brown/beige program via direct interaction with transcription factors, such as C/EBPβ, PPARα, PPARγ, and PGC-1α (Peroxisome proliferator-activated receptor Gamma Coactivator 1-alpha14,15,16). Of note, beige and white differentiation programs share transcriptional regulators, such as C/EBPβ, which has been shown to be sufficient for Ucp1 transcription via direct binding to the Ucp1 proximal promoter in vitro 17,18. Moreover, Cebpb mutant mice display defective thermoregulation19. In addition to transcriptional regulators, growth factors such as FGF21 (Fibroblast Growth Factor-21) and BMP4 (Bone morphogenetic Protein-4), adipokines such as leptin and hormones such as T3 (Triiodothyronin 3) have been identified as being able to induce the brown/beige fat phenotype2,20,21. The T4 to T3 converting enzyme Desiodase 2 (DIO2) is also involved in the browning process22.
The zinc finger transcription factor EGR1 (Early Growth Response-1) is involved in multiple processes including cell proliferation, differentiation, migration, apoptosis, and inflammation in many cell types23,24,25,26,27. Egr1 is expressed in adult adipose tissues28,29 where its overexpression has been linked to obesity and obesity-associated metabolic disorders in both humans and mouse models28,29. Conversely, Egr1-deficient mice are protected from diet-induced obesity29. Consistently, EGR1 inhibits lipolysis and promotes fat accumulation in cultured adipocytes by directly repressing the transcription of the adipose triglyceride lipase (ATGL) gene30. Surprisingly, Egr1 overexpression represses white adipocyte differentiation in the 3T3-L1 and C3H101/2 cell lines31,32.
To understand how Egr1 can both be linked with obesity and adverse metabolic outcomes while repressing differentiation of white adipocytes in culture, we investigated the role of Egr1 in white adipose tissue development during the postnatal period in female mice. We analysed the consequences of Egr1 inhibition for subcutaneous inguinal white adipose tissue (SC-WAT) formation during postnatal and adult periods, using a mouse model deficient for Egr1, with no external stimulation. We also assessed the consequences of Egr1 overexpression for beige differentiation in mesenchymal stem cells.
Results and Discussion
Egr1 −/− mice display inguinal subcutaneous white adipose tissue browning with no external stimulation
The subcutaneous inguinal white adipose tissue (SC-WAT) expands during the post-natal period33 and is the largest white fat depot in mice10,34. Moreover, mouse SC-WAT is comparable in terms of location to the large gluteofemoral subcutaneous depot in humans that is linked to increased risk of developing obesity-related morbidities and mortality35. The size and weight of SC-WAT fat pads were similar in Egr1 +/+ and Egr1 −/− 4-month-old mice, although the total body weight was slightly reduced in Egr1 −/− mice compared to control mice (Fig. 1A–C). These observations suggest that Egr1 loss-of-function leads to a reduced body weight via an increased numbers of active beige adipocytes and potentially through unknown global metabolic processes. Egr1 expression in SC-WAT was detected in blood vessels (Fig. 1D, arrow a) as previously described36 and in adipocytes (Fig. 1D, arrows b,c).
The beige adipocytes in SC-WAT of Egr1 +/+ and Egr1 −/− mice were identified by the expression of UCP1 detected both by immunodetection with DAB staining (Fig. 2A,C) or fluorescent staining (Fig. 2B,D) and by the multilocular aspect of the lipid droplets observed in phase contrast images. The white adipocytes were identified by a unilocular lipid droplet observed in phase contrast images (Fig. 2A–D). SC-WAT from 1-month-old (post-natal) and 4-month-old (adult) Egr1 −/− mice exhibited increased UCP1 staining compared to Egr1 +/+ mice (Fig. 2A–D). At birth and during post-natal period, the inguinal subcutaneous adipose tissue of wild-type mice contains beige adipocytes that are out-numbered by the development of increasing numbers of white adipocytes37 (Fig. 2E). In contrast, we observed a significant increase of the proportion of beige adipocytes and a reduction in the proportion of white adipocytes in SC-WAT of Egr1 −/− mice compared to Egr1 +/+ mice (Fig. 2E). Consistently, the Ucp1 mRNA expression levels were increased in Egr1-deficient SC-WATs compared to equivalent control SC-WATs (Fig. 2F). SC-WATs of Egr1 −/− mice exhibited a higher number of cells compared to Egr1 +/+ mice at 1 and 4 months of age (Fig. 2G), suggesting that EGR1 repressed adipocyte proliferation. However, we did not observe any difference in cell proliferation rates between 1-month-old and 4-month-old Egr1 −/− mice compared to respective controls (see Supplementary Fig. 1). These observations suggest that EGR1 affects cell proliferation of adipocyte progenitors at early stages of adipose tissue development, before 1 month of age. Contrary to our observations, EGR1 has recently been identified to promote self-renewal of adipose progenitors of chin and knee in physio-pathological conditions38. These opposite results highlight the heterogeneity of adipocyte progenitors and adipocytes depending on the fat pad location. Heterozygous Egr1 +/− mice exhibited an intermediate browning phenotype compared to Egr1 +/+ and Egr1 −/− 4-month-old mice (see Supplementary Fig. 2A). We observed an increase in the number of adipocytes and a higher proportion of beige adipocytes in SC-WAT of Egr1 +/− mice compared to Egr1 +/+ mice (see Supplementary Fig. 2B–C). However, the increase was smaller compared to Egr1 −/− mice (Fig. 1E,G).
We conclude that the increase of Ucp1 transcript levels, of UCP1 protein and in the density of UCP1+ cells in SC-WAT of Egr1 −/− mice (Fig. 2) evidences an increase of WAT browning in Egr1 −/− mice with no external stimulation. This result is consistent with the UCP1 increase in visceral perigonadal white adipose previously observed in Egr1 −/− mice under high fat diet feeding29. We conclude that Egr1 deficiency promotes spontaneous SC-WAT browning without external stimulation. These results indicate that the presence of Egr1 in white adipocytes represses spontaneous WAT browning.
Molecular signature of inguinal subcutaneous white adipose tissue browning downstream of Egr1
In order to define the molecular signature underlying WAT browning downstream of Egr1, we performed RNA-sequencing of SC-WAT of 2-week-old Egr1 +/+ and Egr1 −/− mice. 336 differentially expressed genes were significantly detected in Egr1-deficient SC-WAT compared to control SC-WAT. The 132 upregulated differentially expressed genes (Fig. 3A, see Supplementary Fig. 3) were subjected to functional annotation clustering according to their Gene Ontology (GO) classification, in the “Biological Process” category (see Supplementary Fig. 4). Among the 132 upregulated genes, the GO terms “NADH metabolic process”, “Tricarboxylic acid cycle”, “Brown fat cell differentiation” and “Fatty acid metabolic process” exhibited the highest enrichment scores (see Supplementary Fig. 4). Consistent with the beige phenotype (Fig. 2), the key beige adipocyte markers, Ppargc1a, Ucp1, Cox8b, Cidea 7 and other genes known to be involved in the beige differentiation program, Dio2, Pank1, Plin5, Ogdh and Sucla2 11,22,39,40 were identified as upregulated genes (Fig. 3A). The increased expression of these beige genes was confirmed by RT-qPCR at 2 weeks and 4 months of age (Fig. 3B,C). In addition, the generic adipogenesis regulators also known to be involved in beige differentiation, Cepbb 41 and Ppara 42 displayed an increased expression in Egr1-deficient SC-WAT (Fig. 3A–C). Interestingly, there was no modification of expression of signalling molecules controlling beige differentiation such as FGF21, BMP4 or Leptin. This indicates that the transcription factor EGR1 negatively regulates the transcription of beige differentiation markers. To test whether this regulation was direct, we performed Chromatin immunoprecipitation (ChIP) experiments from the SC-WAT of 2-week-old mice on key beige markers. EGR1 was recruited to the Ucp1 proximal promoter in SC-WAT (Fig. 3D,E), showing a direct transcriptional regulation by EGR1. EGR1 was also recruited to the Cebpb promoter (Fig. 3D,E) but not to that of Ppapgc1 gene (Fig. 3D), highlighting a direct and an indirect transcriptional regulation of these two genes by EGR1. These results show that EGR1 exerts its transcriptional repression of the beige program at two levels at least, through the direct recruitment of the main beige differentiation marker Ucp1 and also through the direct recruitment to the Cebpb gene, which is known to regulate Ucp1 transcription17.
The 204 downregulated differentially expressed genes (Fig. 4A, see Supplementary Fig. 5) in SC-WAT of Egr1 −/− mice were enriched for the GO terms “Collagen fibril organization”, “Collagen catabolic process” and “Extracellular matrix organization” (see Supplementary Fig. 6). WAT produces extracellular matrix (ECM) whose composition and remodelling is crucial for adipocyte function43. Conversely, the expansion of adipose tissue during obesity leads to tissue remodelling and is associated with overexpression of Col1a1, Col5a2, Fn1, Dcn and the matrix metalloprotease Mmp2 genes44,45,46,47,48. In the transcriptome of Egr1-deficient SC-WAT, Col1a1, Col1a2, Col5a2, Col14a1, Fn1, Post, Dcn and Mmp2 were downregulated (Fig. 4A), which was confirmed by RT-qPCR in SC-WAT of 2 week- and 4 month-old mice (Fig. 4B,C). We conclude that Egr1-deficiency represses ECM genes associated with obesity. Our results indicate that WAT browning is associated with alteration of ECM composition. The inverse correlation between WAT browning and ECM is consistent with the suppression of brown adipogenesis in favour of fibrogenesis in mice49.
The concomitant upregulation of beige differentiation genes and downregulation of ECM genes is a signature of WAT browning downstream of Egr1 deletion without any external stimulation.
Mutual exclusive expression of Fibronectin and UCP1 in inguinal subcutaneous adipose tissue of Egr1 −/− mice
Adipocyte ECM is an important component of white adipogenesis in normal or pathological conditions43,44,48. However, little is known for ECM-adipocyte interaction during beige adipogenesis. The ECM protein Fibronectin (FN) has been linked with obesity and adipose tissue fibrosis50. EGR1 has been previously shown to directly regulate Fn1 transcription in human glioblastoma cells51. We analysed FN expression in SC-WAT in Egr1 deletion conditions (Fig. 5). Although immunohistochemistry on tissue section is not a quantitative technique, we observed a global decrease of FN expression in SC-WAT, concomitant with an increase of UCP1 expression in 1 month Egr1 −/− compared to Egr1 +/+ mice (Fig. 5A). The decrease of FN protein (Fig. 5A) was fully consistent with the down-regulation of Fn1 mRNA levels (Fig. 4B,C) in Egr1-deficient SC-WAT. FN expression was not observed around the UCP1 + beige adipocytes in SC-WAT of 1-month-old Egr1 −/− mice, while FN was produced by white adipocytes in 1-month-old Egr1 +/+ mice (Fig. 5B). It has to be noticed that FN was observed surrounding the beige adipocyte areas (Fig. 5B). Similar results were found at 4 months of age, where FN was not detected around UCP1+ beige adipocytes, while being expressed around white adipocytes in 4-month-old Egr1 +/+ mice and Egr1 +/+ mice, respectively (Fig. 5D). We conclude that WAT browning in Egr1 −/− mice is associated with an absence of FN expression by UCP1+ beige adipocytes. This result highlights an inverse correlation between the browning process and the expression of the ECM protein FN.
Forced Egr1 expression in mouse mesenchymal stem cells reduces beige marker expression and promotes extracellular matrix gene expression
The spontaneous WAT browning in Egr1 −/− mice and the direct transcriptional regulation of Ucp1 gene by EGR1 in SC-WAT suggested that EGR1 repressed beige adipocyte differentiation. EGR1 gain-of-function experiments were performed in mouse mesenchymal stem cells, C3H10T1/2 cells, cultured under beige adipocyte differentiation conditions. Consistent with the increase in the number of adipocytes in SC-WAT of Egr1 −/− (Fig. 2G), we observed a decreased number of C3H10T1/2-Egr1 cells compared to C3H10T1/2 cells at day 0 and after 8 days of culture in the beige differentiation medium (Fig. 6A,B). Under beige stimulation, C3H10T1/2 cells acquired a beige phenotype, visualized by the appearance of numerous small lipid droplets and UCP1 expression within their cytoplasm (Fig. 6A). In contrast, C3H10T1/2-Egr1 cells did not express UCP1 under beige stimulation, showing that EGR1 repressed the expression of the key thermogenic beige marker (Fig. 6A). Consistent with the absence of UCP1 protein (Fig. 6A), Ucp1 mRNA levels were never increased in the context of Egr1 overexpression (Fig. 6C). This observation fits with EGR1 recruitment to Ucp1 promoter observed in SC-WAT (Fig. 3D,E). However, small lipid droplets were still observed in C3H10T1/2-Egr1 cells, indicating that EGR1 repressed part of the beige phenotype through the repression of UCP1, but did not fully abolish the formation of lipid droplets (Fig. 6A). The expression of Cebpb and Ppara genes was significantly reduced in C3H10T1/2-Egr1 cells compared to control cells as that of Cidea, Plin5, Pank1, Ogdh and Sucla2 genes (Fig. 6C). This showed that beige differentiation and the heat-producing ability of C3H10T1/2 cells were impaired upon Egr1 overexpression. Egr1 overexpression also blocked white adipocyte differentiation in C3H10T1/2 cells (see Supplementary Fig. 7), as previously observed32. The inhibition of both beige and white differentiation programs by EGR1 is to be related with the direct (Cebpb) and indirect transcriptional regulation of generic adipogenesis genes by EGR1 (Fig. 3B–D).
In order to assess whether EGR1 promotes the expression of ECM genes in mesenchymal stem cells in the context of adipocyte differentiation, we analysed the expression of Col5a2, Fn1 and Postn in C3H10T1/2 and C3H10T1/2-Egr1 cells during beige (Fig. 6D) and white (see Supplementary Fig. 7) adipocyte differentiation. The expression of Col5a2, Fn1 and Postn genes was upregulated in Egr1 overexpressing cells, showing that EGR1 activated the expression of ECM genes during adipocyte differentiation. The positive regulation of ECM genes by EGR1 during adipocyte differentiation was consistent with similar regulation in the context of fibrosis, atherosclerosis and tendon repair32,52. We conclude that forced EGR1 expression in mouse mesenchymal stem cells reduces beige marker expression, while promoting ECM gene expression.
In summary, the deletion of Egr1 induces WAT browning by the release of the EGR1-mediated repression of the Cebpb and Ucp1 promoters (Fig. 7A,B). Egr1 loss-of-function causes the overexpression of the beige adipocyte differentiation genes Cebpb and Ppargc1, which both activate the expression of the thermogenic marker Ucp1 through a recruitment to its promoter18,53 (Fig. 7B). In addition, the beige adipocytes metabolic genes Dio2, Cidea, Plin, Pank1, Cox8b, Ogdh and Sucla2a are also upregulated (Fig. 7B) to induce the browning of SC-WAT in Egr1 −/− mice, without any cold stimulation or fasting. The expression of ECM genes is reduced in the context of Egr1 loss-of-function (Fig. 7B). Reciprocally, Egr1 gain-of-function represses the expression of Cebpb and Ucp1 presumably through the recruitment of EGR1 to their promoters (Fig. 7C). In addition, the beige adipocyte metabolic genes Dio2, Cidea, Plin, Pank1, Cox8b, Ogdh and Sucla2a are also downregulated (Fig. 7C), which prevents the differentiation of mesenchymal stem cells into beige adipocytes. The expression of ECM genes is enhanced in the context of Egr1 gain-of-function (Fig. 7C).
The upregulated expression profile of beige differentiation markers and downregulated profile of ECM genes in Egr1-deficient WAT define a molecular signature of beige adipocyte differentiation program and constitute a protective signature against white adipocyte lipid accumulation. This study identifies Egr1 deficiency as a therapeutic approach to counteract obesity.
All experimental procedures using mice were conducted in accordance with the European guidelines (2010/63/UE) and were approved by the French National Ethic Committee for animal experimentation N°05 and are registered under the number 01789.02.
The Egr1 gene was inactivated by homologous recombination with insertion of the LacZ coding sequence within the Egr1 5′ untranslated region in addition to a frameshift mutation upstream of the DNA-binding domain of Egr1 54. The line was maintained on a C57BL/6 J background (Janvier, France). All animals were kept under controlled photo-period (lights on 08:00–20:00 hours) and a diet of commercial rodent chow and tap water ad libitum.
Age-matched groups of 2-week-old, 1-month-old and 4-month-old Egr1 +/+ and Egr1 −/− female mice derived from heterozygous intercrosses of Egr1 +/− were used for the RNA-sequencing, RT-qPCR and immunostaining experiments.
For the RNA-sequencing experiments, we used 3 Egr1 +/+ and 3 Egr1 −/− female mice from 4 different litters. Among these animals, 1 Egr1 +/+ and 1 Egr1 −/− mice were littermates.
For the RT-qPCR experiments, we used 5 Egr1 +/+ and 5 Egr1 −/− 2-week-old female mice from 7 different litters. Among them, 1 Egr1 +/+ and 1 Egr1 −/− mice were littermates. We used 6 Egr1 +/+ and 5 Egr1 −/− 4-month-old female mice from 8 different litters.
For the immunostainings experiments, we used 3 Egr1 +/+ and 2 Egr1 −/− 1-month-old female mice. Among them, 2 Egr1 +/+ and 2 Egr1 −/− were littermates. We used 3 Egr1 +/+, 3 Egr1 −/− and 2 Egr1 +/− 4-month-old female mice. Among these mice, 1 Egr1 +/+, 1 Egr1 −/− and 1 Egr1 +/− were littermates.
In situ hybridization to adipose tissue sections
Inguinal subcutaneous fat pads were isolated from 1-month-old female mice, fixed in 4% paraformaldehyde overnight and processed for in situ hybridization to 6 mm wax tissue sections as previously described55. The digoxigenin-labeled mouse Egr1 probe was used as previously described54.
RNA isolation, sequencing and transcriptomic analysis
Fresh inguinal subcutaneous fat pads were removed from 2-week-old euthanized Egr1 +/+ (N = 3) and Egr1 −/− (N = 3) female mice and homogenized using a mechanical disruption device (Lysing Matrix A, Fast Prep MP1, 4 × 30 s, 6 m.s−1). Total RNA was isolated using the RNeasy mini kit (Qiagen) with 15 min of DNase I (Qiagen) treatment according to the manufacturer’s protocol. Preparation of cDNA libraries and sequencing was performed at the “Ecole Normale Supérieure” Genomic Platform (Paris, France). Ribosomal RNA depletion was performed with the Ribo-Zero kit (Epicentre), using 500 ng of total RNA. Libraries were prepared using the strand specific RNA-Seq library preparation ScriptSeq V2 kit (Epicentre). 51-bp paired-end reads were generated using a HiSeq. 1500 device (Illumina). A mean of 56.9 ± 6.3 million reads passing the Illumina quality filter were obtained for each of the 6 samples. Reads were mapped against the mus musculus reference genome (UCSC Dec. 2011, GRCm38/mm10) using TopHat v2.1.056, Bowtie (v2.2.5)57, and the Release M8 (GRCm38.p4) GTF annotations as a guide. Read counts were assigned to gene features using Feature Counts v1.4.6.p558 and differential expression analysis was performed with DESeq. 2 v1.6.359. Full details of the Galaxy workflow used in this study can be retrieved via the following link: https://mississippi.snv.jussieu.fr/u/emmanuellehavis/w/copy-of-grasostendon-differential-expression-2. Gene Ontology analysis on differentially expressed genes (Padj < 0.05) was performed with DAVID Bioinformatic Resources 6.860. Sequencing data was uploaded to the Gene Expression Omnibus (GEO) database under the accession number GSE91058.
RNA isolation, Reverse-Transcription and quantitative real time PCR
Fresh inguinal subcutaneous fat pads were removed from 2-week-old and 4-month-old euthanized Egr1 +/+ and Egr1 −/− female mice and homogenized using a mechanical disruption device (Lysing Matrix A, Fast Prep MP1, 4 × 30 s, 6 m.s−1). Total RNA was isolated using the RNeasy mini kit (Qiagen) with 15 min of DNase I (Qiagen) treatment according to the manufacturer’s protocol.
For RT-qPCR analyses, 500 ng RNA was Reverse-Transcribed using the High Capacity Retrotranscription kit (Applied Biosystems). Quantitative PCR was performed using SYBR Green PCR Master Mix (Applied Biosystems) using primers listed in Supplementary Table 1. We used Actb as housekeeping gene for the analysis of the SC-WAT from 2-week-old mice and Rplp0 for the analysis of the SC-WAT from 4-month-old mice and C3H10T1/2 and C3H10T1/2-Egr1 cells. The relative mRNA levels were calculated using the 2−ΔΔCt method61. The ΔCt values were obtained by calculating the differences: Ct(gene of interest) – Ct(housekeeping gene) in each sample. We obtained the ΔΔCt values by calculating the differences between ΔCt(Experiment) and the average of ΔCt(control) values. For mRNA level analysis in SC-WAT, Egr1 −/− values were considered as experimental and Egr1 +/+ as controls. The controls were normalized to 1.
5 to 6 independent RNA samples of 2-week-old and 4-month-old Egr1 +/+ and Egr1 −/− female mice were analysed in duplicate. For mRNA level analysis in cell cultures, C3H10T1/2-Egr1 values were considered as experimental and C3H10T1/2 as controls. 6 independent RNA samples were analysed in duplicate for each time point.
ChIP assays were performed with previously reported protocol62 on the inguinal subcutaneous adipose tissue isolated from 60 2-week-old mice, homogenized using a mechanical disruption device (Lysing Matrix A, Fast Prep MP1, 3 × 30 sec). 8 µg of the rabbit polyclonal anti-Egr-1/Krox24 (C-19) antibody (Santa Cruz Biotechnology) or 8 µg of the goat anti-mouse IgG2b (Southern biotechnology) were used to immunoprecipitate 30 µg of sonicated chromatin. ChIP products were analyzed by quantitative PCR. 15 µg of chromatin was isolated before chromatin immunoprecipitation, to be used as positive control for the PCR experiments (Input). ChIP products and Inputs were analyzed by quantitative PCR to amplify the promoter regions upstream the Cebpb (−660 bp; −530 bp), Ppargc1a (−860 bp; −730 bp), Ucp1 (−170 bp; + 20 bp) and Gapdh (−2,9 Kb; −2,7 Kb; negative control) coding sequences. qPCR amplicons were loaded on a 1% agarose gel. The primer list is displayed in Supplementary Table 1.
Fresh inguinal subcutaneous fat pads were removed from 1-month-old and 4-month-old euthanized Egr1 +/+ and Egr1 −/− female mice, fixed in 4% formaldehyde overnight at 4 °C and processed for immunohistochemistry on 12 µm wax tissue sections, as previously described63. After wax removal, for UCP1 immunodetection, heat-induced epitope retrieval was performed by incubating sections 5 min at 95 °C in Glycine-HCl buffer (0.05 M Glycine, pH3.5). UCP1 protein was detected using rabbit polyclonal antibody (1:200, ab10983, Abcam), followed by secondary anti-rabbit HRP conjugate antibody (1:200, 170-6515, Biorad) and DiaminoBenzidine Tetra-Hydrochloride protocol (DAB) staining or followed by secondary anti-rabbit fluorescent antibody (1:200, Goat anti-Rabbit Alexa 488, A11008, Invitrogen) staining.
For fibronectin immunodetection, heat-induced epitope retrieval was performed by incubating sections 7 min at 95 °C in citrate buffer (10 mM, pH 6). Fibronectin protein was detected using mouse monoclonal antibody (1:200, F7387, Sigma), followed by secondary anti-mouse fluorescent antibody (1:200, Goat anti-Mouse Alexa 555, A21422, Invitrogen) staining.
Nuclei were visualised either by Hematoxylin & Eosin (H&E) histological staining using a standard protocol or by DAPI staining according to manufacturer’s instructions (DAPI, D9542, Sigma).
C3H10T1/2 and C3H10T1/2-Egr1 cells were cultured in beige or white adipocyte differentiation medium for 8 and 10 days, respectively, on cover slips. Cells were fixed with 4% Paraformaldehyde (Sigma) for 15 min. UCP1 protein was detected using rabbit polyclonal antibody (1:200, ab10983, Abcam), followed by secondary anti-rabbit HRP conjugate antibody (1:200, 170-6515, Biorad) and DiaminoBenzidine Tetra-Hydrochloride protocol (DAB) staining. Hematoxylin & Eosin (H & E) histological staining was performed using a standard protocol.
Cell number measurements
All cell number measurements were performed using the free software ImageJ (Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997–2012).
To quantify the number of white and beige adipocytes in SC-WAT of Egr1 +/++/+ and Egr1 −/− mice, cell number was counted per arbitrary unit area on sections originating from 1-month-old and 4-month-old female mice. The beige adipocytes were identified by the expression of UCP1 detected by immunodetection with DAB staining or fluorescent staining and by the multilocular aspect of the lipid droplets combined with positive Hematoxylin or DAPI nucleus staining. The white adipocytes were identified both by a unilocular lipid droplet and positive DAPI staining.
The number of beige and white cells in 1-month-old mice was counted from 10 sections originating from 6 fat pads of 2 Egr1 +/+ mice and from 11 sections originating from 4 fat pads of 2 Egr1 −/− mice. The number of beige and white cells in 4-month-old mice was counted from 13 sections originating from 6 fat pads of 3 Egr1 +/+ mice, from 14 sections originating from 6 fat pads of 3 Egr1 −/− mice and from 8 sections originating from 4 fat pads of 2 Egr1 +/− mice.
To quantify the total number of cells in SC-WAT of Egr1 +/+ and Egr1 −/− mice, the number of DAPI + cells was counted per arbitrary unit area on sections originating from 1-month-old and 4-month-old female mice. The number of DAPI + cells in 1-month-old mice was counted from 9 sections originating from 6 fat pads of 3 Egr1 +/+ mice and from 11 sections originating from 4 fat pads of 2 Egr1 −/− mice. The number of DAPI + cells in 4-month-old mice was counted from 11 sections originating from 6 fat pads of 3 Egr1 +/+ mice, from 12 sections originating from 6 fat pads of 3 Egr1 −/− mice and from 8 sections originating from 4 fat pads of 2 Egr1 +/− mice.
To quantify the number of C3H10T1/2 and C3H10T1/2-Egr1 cells at Day 0 and Day 8 of beige adipocyte differentiation conditions the number of Hematoxylin-positive cells was counted per unit area from 10 wells for each condition.
Mouse mesenchymal stem cells, C3H10T1/264 and the stable Egr1 overexpressing counterparts, C3H10T1/2-Egr132 cells, were plated to 6-well plates at a density of 330,000 cells/well and grown in Dulbecco’s Modified Eagle’s Medium (DMEM, Invitrogen) supplemented with 10% foetal bovine serum (FBS, Sigma), 1% penicillin-streptomycin (Sigma), 1% Glutamin (Sigma), 800 μg/ml G418 Geneticin (Sigma) and incubated at 37 °C in humidified atmosphere with 5% CO2.
Confluent cells were cultured in beige differentiation induction medium for 2 days and in beige maturation medium for 6 days according to published protocols65. Day 0 corresponds to the addition of beige differentiation induction medium on confluent cells. Beige differentiation induction medium includes DMEM, 10% FBS, 1% penicillin-streptomycin, 10 µg/mL Insulin (Sigma), 0.25 µM Dexamethasone (Sigma), 0.5 mM 3-Isobutyl-1-methylxanthine (IBMX, Sigma), 50 nM 3.3′,5-Triiodo-L-thyronine sodium salt (T3, Sigma), 20 µM Curcumin (Sigma). The beige maturation medium comprises DMEM, 10% FBS, 1% penicillin-streptomycin, 10 µg/mL Insulin (Sigma), 50 nM 3,3′,5-Triiodo-L-thyronine sodium salt (T3, Sigma), 20 µM Curcumin (Sigma), 1 µM Rosiglitazone (Sigma). The maturation medium was changed every 2 days. Cells subjected to beige adipocyte differentiation medium were fixed for histological analysis or lysed for gene expression analysis at Day 0, Day 1, Day 6 and Day 8.
Confluent cells were cultured in white differentiation induction medium for 2 days and in white maturation medium for 8 days. Day 0 corresponds to the addition of white differentiation medium. White differentiation induction medium includes DMEM, 10% FBS, 1% penicillin-streptomycin, 10 µg/mL Insulin (Sigma), 0.25 µM Dexamethasone (Sigma), 0.5 mM 3-Isobutyl-1-methylxanthine (IBMX, Sigma), 30 nM 3.3′,5-Triiodo-L-thyronine sodium salt (T3, Sigma). The white maturation medium comprises DMEM, 10% FBS, 1% penicillin-streptomycin and 10 µg/mL Insulin (Sigma). The maturation medium was changed every 2 days. Cells subjected to white adipocyte differentiation medium were stopped at Day 0, Day 1, Day 4 and Day 10 for histological and gene expression analysis by RT-qPCR.
Oil Red O staining
C3H10T1/2 and C3H10T1/2-Egr1 cells were cultured in beige or white adipocyte differentiation medium for 8 and 10 days, respectively. Cells were fixed with 4% Paraformaldehyde (Sigma) for 15 min and washed twice with excess distilled H2O (Millipore). 60% Isopropanol was added for 5 min and replaced with an Oil Red O (Sigma) staining mixture, consisting of Oil Red O solution (0.5% Oil Red O dye in Isopropanol) and water in a 6:4 ratio, for 15 min. Cells were rinsed three times in distilled H2O, followed by a standard Hematoxylin & Eosin staining protocol.
Data was analysed using the non-parametric Mann-Withney test or ANOVA test with Graphpad Prism V6. Results are shown as means ± standard deviations. The p-values are indicated either with the value or with * or #.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
We thank Kacey Marra, Peter Rubin and Erin Kershaw from the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States for comments on the manuscript and their expertise in adipose tissue biology. We thank Estelle Hirsinger from IBPS, Paris, France for comments on the manuscript. We thank Marie-Ange Bonnin from IBPS, Paris, France for technical support. We thank Sophie Lemoine and Stéphane Le Crom, from IBENS, Paris, France and Christophe Antoniewsky from ARTbio Bioinformatics Analysis Facility, Paris, France, for the bioinformatics analyses of the RNA-sequencing. We thank Sophie Gournet for illustrations. This work was supported by the Fondation pour la Recherche Médicale (FRM) DEQ. 20140329500 and FDT20150532272, Institut national de la santé et de la recherche Médicale (Inserm), Centre National de la Recherche Scientifique (CNRS), Université Pierre et Marie Curie (UPMC), Sorbonne Universités Emergence (SU-16-R-EMR-33) and the Agence Nationale de la Recherche (contracts ANR-10-BLAN-1219, ANR- 12-BSV1-0038). The École normale supérieure genomic platform was supported by the France Génomique national infrastructure, funded as part of the “Investissements d’Avenir” program managed by the Agence Nationale de la Recherche (contract ANR-10-INBS-09).